AV

Avient Corporation

AVNTBasic MaterialsNASDAQ

Specialty Chemicals

PriceMA150MA200
Loading chart…
End-of-day data · ScananceOpen live chart on TradingView ↗
Indicator snapshot · Today
Premium
Today's indicator reading is locked

Free plan shows historical signals only. Upgrade to see this ticker's current MA150, MA200, RSI, and MACD readings.

Upgrade to see today →
Financials · Annual
Revenue
$3.26B
+0.6% YoY
Net Income
$81.9M
-51.7% YoY
EBITDA
$396.2M
-22.3% YoY
Free Cash Flow
$353.8M

Scan Results

Daily timeframe
4 recent days hidden. Fresh signals are a Premium featureUpgrade →
DateIndicatorDetails
Jul 11 MACD Negative CrossoverHistogram -0.1773, negative momentum
Jul 10 MACD Negative CrossoverHistogram -0.1264, negative momentum
About Avient Corporation

Headquartered within the basic materials sector, Avient Corporation focuses on Specialty Chemicals services and products. Avient Corporation operates as a formulator of material solutions in the United States, Canada, Mexico, Europe, South America, and Asia. With a market capitalization of $3.39B, it sits in mid-cap territory. The company operates in two segments, Color, Additives and Inks; and Specialty Engineered Materials.

Key stats
Market Cap$3.39B
P/E (TTM)21.49
Fwd P/E10.93
EPS$1.72
Beta1.28
52W Change+13.8%
Dividend Yield2.89%
ROE6.7%
Analysis

The company holds $427.6M in cash, though total debt stands at $1.92B. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. Annual free cash flow of $353.8M supports ongoing capital allocation decisions and provides a cushion against unexpected expenses or downturns. Return on equity stands at 6.7%, which is modest for the sector. ROE measures how effectively a company uses shareholder capital to generate profits. ROA of 4.0% is on the lower side, which is common in asset-heavy industries. Revenue has been relatively flat, moving from $3.32B (2021) to $3.26B (2025).

As with any equity investment, AVNT carries market risk, sector-specific risk, and company-specific risk that investors should evaluate in the context of their own portfolios. It is important to consider these factors alongside broader market conditions and individual financial goals when reviewing AVNT.

Links
More Basic Materials stocks
Browse all stocks →
Not financial advice. Scanance is an educational tool. Past performance does not guarantee future results.PrivacyTerms